miRecule is a biotechnology company developing microRNA-based therapeutics. It offers a miRecule genomics-based drug discovery platform that integrates genomic sequencing, expression, and prognostic data from cancer patients with screening data of microRNA mimics to identify microRNA candidates for miR replacement therapy.